NistuFe (KYLK01)

About Keylika

Keylika is a private, preclinical-stage biotech based in San Francisco, pioneering a combined drug discovery and delivery platform focused on metallodrugs and transdermal administration. The company's primary asset, NistuFe (KYLK01), is a novel iron complex formulated as a skin patch designed to treat iron deficiency anemia by bypassing the gastrointestinal tract, aiming to combine the efficacy of IV iron with the convenience of oral supplements. The company is founded by a team with deep expertise in material science, microsystems, and drug delivery, and is currently pre-revenue, seeking to address a significant global unmet medical need.

Therapeutic Areas